Details for Patent: 7,012,066
✉ Email this page to a colleague
Summary for Patent: 7,012,066
| Title: | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| Abstract: | The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease. |
| Inventor(s): | Anil K. Saksena, Viyyoor Moopil Girijavallabhan, Raymond G. Lovey, Edwin Jao, Frank Bennett, Jinping L. Mc Cormick, Haiyan Wang, Russell E. Pike, Stephane L. Bogen, Tin-Yau Chan, Yi-Tsung Liu, Zhaoning Zhu, F. George Njoroge, Ashok Arasappan, Tejal Parekh, Ashit K. Ganguly, Kevin X. Chen, Srikanth Venkatraman, Henry A. Vaccaro, Patrick A. Pinto, Bama Santhanam, Scott Jeffrey Kemp, Odile Esther Levy, Marguerita Lim-Wilby, Susan Y. Tamura, Wanli Wu, Siska Hendrata, Yuhua Huang |
| Assignee: | Merck Sharp and Dohme LLC , Dendreon Pharmaceuticals LLC |
| Application Number: | US09/908,955 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,012,066
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,012,066
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1385870 | ⤷ Start Trial | C300506 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1385870 | ⤷ Start Trial | 91910 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1385870 | ⤷ Start Trial | CA 2011 00036 | Denmark | ⤷ Start Trial |
| European Patent Office | 1385870 | ⤷ Start Trial | 1190037-0 | Sweden | ⤷ Start Trial |
| European Patent Office | 1385870 | ⤷ Start Trial | 12C0002 | France | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
